サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433394

皮膚生検の世界市場：2023-2030年

Global Skin Biopsy Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 115 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮膚生検の世界市場：2023-2030年
出版日: 2023年12月15日
発行: Orion Market Research
ページ情報: 英文 115 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚生検の世界市場は、予測期間（2023-2030年）にCAGR 6.8%でかなりの成長が見込まれます。高品質なスキンケア製品、特にHA、ペプチド、抗酸化剤など、科学的に検証された優れた成分を配合した製品に対する消費者の需要は増加の一途をたどっています。新製品の発売は、スキンケア分野への関心と調査を刺激します。例えば、2022年12月、Hydrinity Accelerated Skin Science社は、ヒアルロン酸（HA）、PPM技術、多数のペプチドや抗酸化物質といったよく知られた成分を配合した新しいフェイシャルスキンケアラインを発売しました。この新しいスキンケアラインには、エイジングサインを軽減し、キメを整え、肌の回復を促進するようデザインされた、リニューアルHA美容液、保湿・ヒーリング美容液、軽量で微生物にやさしい浄化ミストが含まれています。しかし、皮膚生検のコストが高いため、低所得国での成長が抑制される可能性があります。

セグメント別展望

診断検査室サブセグメントが皮膚生検の世界市場でかなりのシェアを占めると予想される

エンドユーザーの中では、診断検査室サブセグメントが世界の皮膚生検市場でかなりのシェアを占めると予想されます。このセグメントの成長は革新的な診断アプローチによるものです。アルツハイマー病の診断に皮膚生検サンプルを使用することは、神経学における革新的な手法です。このような革新的アプローチは皮膚生検の用途を皮膚科以外にも広げ、皮膚生検業界の多様化に貢献しています。例えば、2023年2月、SynapsDx社は皮膚に基づくアルツハイマー病診断テストを発表準備中です。Synaps社は3つのバイオマーカーを用いてアルツハイマー病を診断し、他の認知症と鑑別します。第一の診断は、患者の皮膚サンプルから採取した線維芽細胞の細胞増殖を測定する形態計測イメージングに基づいています。アルツハイマー病患者には大きな凝集体が少ないです。

地域別展望

世界の皮膚生検市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに区分されます。このうち、アジア太平洋地域は、皮膚の健康、診断、治療プロセスに対する意識の高まりにより、予測期間を通じて市場を牽引することが予想されるため、世界市場で突出したシェアを占めると予想されます。

北米が世界の皮膚生検市場を占める

この地域の成長は、小児皮膚生検の医療ニーズに起因しています。小児皮膚疾患の診断における皮膚生検の重要性が強調されています。その結果、小児と青少年が生検症例のかなりの割合を占めるため、若年患者に合わせた生検装置とサービスの需要が市場拡大を促進する可能性があります。

国立行政院によると、2023年6月に1308件の生検記録を分析した研究では、男性優位であり、患者の大半が青年であることが明らかになった。さらに研究によると、小児皮膚生検の実施率は12.9％で、83.9％の患者が1回の生検を受けた。患者の大多数は複数回の生検を受けており、98％が診断目的で生検を受けていました。患者の平均年齢は12歳で、男性が女性を上回った。この研究は、小児患者における皮膚生検の重要性と、臨床と病理組織学的一致の高さを強調しています。ハンセン病と丘疹扁平上皮症が最も多い症例でした。

例えば2019年6月、Prosciaは皮膚生検の事前スクリーニングと分類を行うDermAIを発表しました。ProsciaのAIを搭載したソフトウェアは、皮膚疾患の変異を診断前のカテゴリーに分類し、病理診断の信頼性、品質、スピードを高め、エラーを減らし、検査室の効率を向上させることができます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Cardinal Health, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Becton, Dickinson, and Co.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Bio-Rad Laboratories, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向

第4章 市場セグメンテーション

  • 皮膚生検の世界市場：タイプ別
    • 薄片生検
    • パンチ生検
    • 摘出生検
  • 皮膚生検の世界市場：適応症別
    • 皮膚がん診断と病期分類
    • 光線性角化症
    • 皮膚炎
    • その他（毛髪・爪疾患、自己免疫性皮膚疾患）
  • 皮膚生検の世界市場：エンドユーザー別
    • 病院
    • 診断研究所
    • その他（研究機関・学術センター、皮膚科医・病理医）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • AccuTec, Inc.
  • Danaher Corp.
  • Hologic, Inc.
  • Innovia Medical
  • Integra LifeSciences
  • Jai Surgicals Ltd.
  • Kai Corp.
  • NIKON CORP.
  • Paramount Surgimed Ltd.
  • PerkinElmer U.S. LLC
  • Roche Diagnostics India Pvt. Ltd.
  • Stryker Corp.
  • Thermo Fisher Scientific Inc.
  • Vernacare
  • World Precision Instruments
  • Sysmex Corp.
  • Bruker Corp.
  • Illumina, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL EXCISIONAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SKIN BIOPSY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SKIN BIOPSY MARKET SHARE BY INDICATION, 2022 VS 2030 (%)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SKIN BIOPSY MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027970

Global Skin Biopsy Market Size, Share &Trends Analysis Report by Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), by Indication (Skin Cancer Diagnosis and Staging, Actinic keratosis, Dermatitis, and Others) and by End-User (Hospitals, Diagnostic Laboratories, and Others), Forecast Period (2023-2030)

The global skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030).The market's growth is attributed to the demand for advanced skincare products. Consumer demand for high-quality skincare products, particularly those designed with prominent and scientifically validated components such as HA, peptides, and antioxidants, continues to rise. The launch of new products stimulates interest and investigation in the skincare sector. For instance, in December 2022, Hydrinity Accelerated Skin Science launched new facial skin care line with well-known ingredients of hyaluronic acid (HA), PPM technology, and numerous peptides and antioxidants. The new skin care line includes a renewing HA serum, a hydrating and healing serum, and a lightweight, microbiome-friendly purifying mist, all designed to reduce signs of aging, improve texture, and accelerate skin healing. However, the high cost of skin biopsy may restrain its growth in low-income economies.

Segmental Outlook

The global skin biopsy market is segmented on the type, indication, and end-user. Based on the type, the market is sub-segmented into shave biopsy, punch biopsy, and excisional biopsy. Based on the indication, the market is sub-segmented into skin cancer diagnosis and staging, actinic keratosis, dermatitis, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals, diagnostic laboratories, and others. The skin cancer diagnosis and staging subcategory is expected to capture a significant portion of the market share within the indication segment. The growth can be attributed to the skin cancer prevalence is increasing, and skin diseases have been diagnosed earlier. In addition, skin cancer needs to be detected and treated as soon as possible to avoid the need for surgery in the case of a dangerous melanoma or other skin cancer.

Diagnostic Laboratories Sub-Segment is Anticipated to Hold a Considerable Share of the global Skin Biopsy Market

Among the end-user, the diagnostic laboratories sub-segment is expected to hold a considerable share in the global Skin Biopsy market. The segmental growth is attributed to the innovative diagnostic approaches. The use of skin biopsy samples to diagnose Alzheimer's disease is an innovative method in neurology. Such innovative approaches broaden the applications of skin biopsies outside dermatology, helping to diversify the skin biopsy industry. For instance, in February 2023, SynapsDx Prepares Launched Skin-Based Alzheimer's Disease Diagnostic Test. Synaps uses three biomarkers to diagnose Alzheimer's disease and differentiate it from other dementia forms. The primary diagnosis is based on morphometric imaging, that measures cell growth in fibroblasts from a patient's skin sample. Alzheimer's patients have fewer large aggregates.

Regional Outlook

The global skin biopsy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increased awareness of skin health, diagnosis, and treatment processes is expected to drive the market throughout the forecast period.

The North America Holds Considering the global Skin Biopsy Market

Regional growth is attributed to the medical need for pediatric skin biopsies. The observations highlight the importance of skin biopsies in the diagnosis of pediatric skin disorders. As a result children and adolescents account for a sizable proportion of biopsy cases, the demand for biopsy equipment and services tailored to younger patients has the potential to drive market expansion.

According to the National Institute of Government, in June 2023, a study analyzed 1308 biopsy records, revealing a male predominance and a majority of patients were adolescents. Furthermore, study found that 12.9% of pediatric skin biopsies were performed, with 83.9% of patients underwent a single biopsy. The majority of patients underwent multiple biopsies, with 98% performing a biopsy for diagnostic purposes. The mean age of patients was 12 years, with males outnumbering females. The study emphasizes the importance of skin biopsies in pediatric patients and the high clinic-histopathologic agreement. Leprosy and papulosquamous diseases were the most common cases.

Market Players Outlook

The major companies serving the skin biopsy market includes Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

For instance in June 2019,Proscia Launched DermAI to Pre-Screen and Classify Skin Biopsies. Proscia's AI-powered software can classify skin disease variants into pre-diagnostic categories, enhancing pathology confidence, quality, and speed, reducing errors and improving laboratory efficiency.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global skin biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Cardinal Health, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton, Dickinson, and Co.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Bio-Rad Laboratories, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments

4. Market Segmentation

  • 4.1. Global Skin Biopsy Market by Type
    • 4.1.1. Shave Biopsy
    • 4.1.2. Punch Biopsy
    • 4.1.3. Excisional Biopsy
  • 4.2. Global Skin Biopsy Market by Indication
    • 4.2.1. Skin Cancer Diagnosis and Staging
    • 4.2.2. Actinic Keratosis
    • 4.2.3. Dermatitis
    • 4.2.4. Others (Hair and Nail Disorders, and Autoimmune Skin Disorders)
  • 4.3. Global Skin Biopsy Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostic Laboratories
    • 4.3.3. Others (Research Institutions and Academic Centers, Dermatologists and Pathologists)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AccuTec, Inc.
  • 6.2. Danaher Corp.
  • 6.3. Hologic, Inc.
  • 6.4. Innovia Medical
  • 6.5. Integra LifeSciences
  • 6.6. Jai Surgicals Ltd.
  • 6.7. Kai Corp.
  • 6.8. NIKON CORP.
  • 6.9. Paramount Surgimed Ltd.
  • 6.10. PerkinElmer U.S. LLC
  • 6.11. Roche Diagnostics India Pvt. Ltd.
  • 6.12. Stryker Corp.
  • 6.13. Thermo Fisher Scientific Inc.
  • 6.14. Vernacare
  • 6.15. World Precision Instruments
  • 6.16. Sysmex Corp.
  • 6.17. Bruker Corp.
  • 6.18. Illumina, Inc.